This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Alan Xiao: Innovator in Infection Treatment
Introduction
Alan Xiao is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of infections. With a total of 2 patents to his name, his work has the potential to impact patient care significantly.
Latest Patents
Alan Xiao's latest patents focus on innovative methods for treating infections in patients with impaired renal function. One of his key patents involves administering ceftolozane/tazobactam to human patients with end-stage renal disease who are undergoing hemodialysis. This method addresses complicated intra-abdominal infections and complicated urinary tract infections, showcasing his commitment to improving treatment options for vulnerable patient populations.
Career Highlights
Alan Xiao is currently employed at Merck Sharp & Dohme Corp., a leading pharmaceutical company. His role there allows him to work on groundbreaking research and development projects that aim to enhance medical treatments and patient outcomes.
Collaborations
Throughout his career, Alan has collaborated with esteemed colleagues, including Benjamin A. Miller and Gopal Krishna. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Alan Xiao's contributions to the field of infection treatment exemplify the importance of innovation in medicine. His patents and work at Merck Sharp & Dohme Corp. highlight his dedication to improving healthcare for patients with complex medical needs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
